VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
OSUR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
OSUROraSure Technologies, Inc.
$3.99$275M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
OSUR logo

OraSure Technologies, Inc.

OSUR
NASDAQ · Medical Instruments
$3.99
At close - Sep 23, 4:00 PM EDT - USD
Market Cap$275M
P/E-4.2x
52W High$4.58
Volume383.92K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

OraSure Faces Severe Revenue Contraction and Liquidity

OraSure Technologies is currently navigating a critical transition period characterized by a 99.9% year-over-year revenue decline in 2026Q1 as pandemic-era demand evaporates. The company's inability to pivot its cost structure, evidenced by an operating margin...

GrowthContracting
ProfitabilityNegative
ValuationReview
TechnicalsHealthy
Explore valuation models
MARKET ACTION

OSUR price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

3/12 Beats

EPS beat 3 of last 12 quarters

02

Valuation risk

-112% Peers

P/E is 112% below peer median

03

Market leadership

RS 72 · Avg

Average momentum (RS Rating: 72)

04

Healthy Uptrend

Uptrend

Price > 50DMA > 200DMA

Next CatalystEstimated earnings · Nov 5

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
OSUR+67.65%
S&P 500 (^GSPC)+12.39%
1-Year Return
OSUR+21.65%
S&P 500 (^GSPC)+15.77%
3-Year Return
OSUR-30.61%
S&P 500 (^GSPC)+75.36%
5-Year Return
OSUR-64.31%
S&P 500 (^GSPC)+73.36%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
-4.2x
Forward P/E
N/A
EV/EBITDA
N/A
FCF YieldCash Flow
N/A

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
-4.2x
11.4x
0th· Low
EV/EBITDA
N/A
31.8x
N/A
Price/FCF
N/A
11.4x
N/A
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue
$115M-38.1% YoY
Net income
-$69M-252.5% YoY
Free cash flow
-$53K-100.2% YoY
Operating margin
-59.2%-48.1 pts YoY
ROIC (TTM)-32.8%
Avg ROIC 5Y-
ROE (TTM)-18.3%
Piotroski Score3 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate3/12 (25%)
Revenue Beat Rate11/12 (92%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 5, 2026
$0.09+133.3%
vs -$0.27
$31M+5.3%
vs $29M
Q2 2026
May 6, 2026
-$0.32-39.1%
vs -$0.23
$28M+0.8%
vs $28M
Q1 2026
Feb 25, 2026
-$0.27-58.8%
vs -$0.17
$27M+1.0%
vs $26M
Q4 2025
Nov 5, 2025
-$0.19-18.8%
vs -$0.16
$27M-7.0%
vs $29M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
Seeking Alpha·Aug 6, 2026
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

MarketBeat·Aug 6, 2026
OraSure Technologies Q2 Earnings Call Highlights

OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management products supported results.

Globe News Wire·Aug 5, 2026
OraSure Announces Second Quarter 2026 Financial Results

BETHLEHEM, Pa. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2026. "Our Q2 results demonstrate continued progress in our return-to-growth trajectory, with revenue of $30.

GlobeNewsWire·Aug 5, 2026
OraSure Announces Second Quarter 2026 Financial Results

BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2026.

Filtered for OraSure Technologies, Inc.More Headlines
04

Compare before deciding

Benchmark OSUR against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for OraSure Technologies, Inc. (OSUR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
OSUR logoOSUROraSure Technologies, Inc.Current
$3.99$274.71M-4.24-38.1%-59.76%-18.3%—
QDEL logoQDELQuidelOrtho Corporation
$10.34$705.09M-0.62-1.89%-39.2%-55.3%—
IDXX logoIDXXIDEXX Laboratories, Inc.
$522.02$41.18B39.9110.42%25.03%71.96%—
ABT logoABTAbbott Laboratories
$103.53$180.32B27.835.67%13.91%12.09%—
BDX logoBDXBecton, Dickinson and Company
$182.52$50.29B31.318.23%4.52%3.79%—
HOLX logoHOLXHologic, Inc.
$76.01$16.97B30.531.74%13.18%11.01%—

Compare OSUR vs Peers

OraSure Technologies, Inc. (OSUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs QDEL

Most directly comparable listed peer for OSUR.

Scale Benchmark

vs TMO

Larger-name benchmark to compare OSUR against a more recognizable public peer.

Peer Set

Compare Top 5

vs QDEL, IDXX, ABT, BDX

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

OSUR SEC Filings & Documents

OraSure Technologies, Inc. (OSUR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 5, 2026·SEC

Material company update

Jun 11, 2026·SEC

Material company update

May 6, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 9, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Mar 11, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 7, 2026·SEC

FY 2026

May 8, 2026·SEC

FY 2025

Nov 5, 2025·SEC

Get notified when OSUR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

OSUR Frequently Asked Questions

OraSure Technologies, Inc. (OSUR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is OraSure Technologies, Inc.'s revenue?

OraSure Technologies, Inc. (OSUR) reported $112.4M in revenue for fiscal year 2025. This represents a 64% increase from $68.7M in 1996.

How fast is OraSure Technologies, Inc. growing?

OraSure Technologies, Inc. (OSUR) saw revenue decline by 38.1% over the past year.

Is OSUR profitable?

OraSure Technologies, Inc. (OSUR) reported a net loss of $49.1M for fiscal year 2025.

Dividend & Returns
What is OSUR's return on equity?

OraSure Technologies, Inc. (OSUR) has a return on equity (ROE) of -18.3%. Negative ROE indicates the company is unprofitable.

What is OraSure Technologies, Inc.'s free cash flow?

OraSure Technologies, Inc. (OSUR) had negative free cash flow of $62.9M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in OSUR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →